These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunological Effect of Skin Allograft in Burn Treatment: Impact on Future Vascularized Composite Allotransplantation. Garza RM; Press BH; Tyan DB; Karanas YL; Lee GK J Burn Care Res; 2017; 38(3):169-173. PubMed ID: 27801681 [TBL] [Abstract][Full Text] [Related]
8. Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation. Klein HJ; Schanz U; Hivelin M; Waldner M; Koljonen V; Guggenheim M; Giovanoli P; Gorantla VS; Fehr T; Plock JA Burns; 2016 Mar; 42(2):246-57. PubMed ID: 26392022 [TBL] [Abstract][Full Text] [Related]
9. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis. Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216 [TBL] [Abstract][Full Text] [Related]
10. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340 [TBL] [Abstract][Full Text] [Related]
11. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study. Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423 [TBL] [Abstract][Full Text] [Related]
12. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749 [TBL] [Abstract][Full Text] [Related]
13. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284 [TBL] [Abstract][Full Text] [Related]
14. De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation - a retrospective study. Weissenbacher A; Vrakas G; Chen M; Reddy S; Allan P; Giele H; Barnardo MCNM; Vaidya A; Friend PJ; Fuggle SV Transpl Int; 2018 Apr; 31(4):398-407. PubMed ID: 29150964 [TBL] [Abstract][Full Text] [Related]
15. [The clinical use of cryopreserved human skin allografts for transplantation]. Martínez-Flores F; Chacón-Gómez M; Madinaveitia-Villanueva JA; Barrera-Lopez A; Aguirre-Cruz L; Querevalu-Murillo W Cir Cir; 2015; 83(6):485-91. PubMed ID: 26187707 [TBL] [Abstract][Full Text] [Related]
16. Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood. O'Connor MJ; Lind C; Tang X; Gossett J; Weber J; Monos D; Shaddy RE J Heart Lung Transplant; 2013 Apr; 32(4):390-7. PubMed ID: 23395085 [TBL] [Abstract][Full Text] [Related]
17. Panel-reactive antibodies late after allograft implantation in children. Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851 [TBL] [Abstract][Full Text] [Related]